SCHEMBL380146

SCHEMBL380146

COC(=O)c1ccccc1[C]=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
LMNA P02545 2/20 0.57
ALDH1A1 P00352 3/20 0.55
HSD17B10 Q99714 2/20 0.55
CFTR P13569 1/20 0.55
KDM4E B2RXH2 3/20 0.53
POLB P06746 1/20 0.53
ATM Q13315 1/20 0.53
MAPT P10636 3/20 0.49
KMT2A Q03164 2/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA5A P35218 1/20 0.49
CA9 Q16790 1/20 0.49
ALOX15 P16050 1/20 0.49
THRB P10828 1/20 0.48
HPGD P15428 1/20 0.47
SLC6A3 Q01959 3/20 0.47
MYC P01106 1/20 0.47
SLC6A4 P31645 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70467 0.86 TSHR (0.59) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL8834011 0.83 CA1 (0.50) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL29946551 0.82 TSHR (0.55) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL16618748 0.82 TSHR (0.55) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL498003 0.82 TSHR (0.55) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL181067 0.82 ALDH1A1 (0.55) TSHRLMNAALDH1A1HSD17B10CFTR
SCHEMBL4652940 0.82 NPC1 (0.37) TSHRLMNAALDH1A1HSD17B10CFTR
Dimethyl Phthalate SCHEMBL34630 0.80 TSHR (0.74) TSHRLMNAALDH1A1HSD17B10CFTR
Dimethyl Phthalate SCHEMBL790124 0.80 TSHR (0.74) TSHRLMNAALDH1A1HSD17B10CFTR
Dimethyl Phthalate SCHEMBL29669976 0.80 TSHR (0.74) TSHRLMNAALDH1A1HSD17B10CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329913-B2 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof ZERIA PHARMACEUTICAL CO., LTD. (JP) 2012-12-11 US claimed
EP-1852433-B1 CARBAZOLE DERIVATIVE, SOLVATE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ZERIA PHARM CO LTD (JP) 2011-11-23 EP claimed
US-20100286210-A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof ZERIA PHARMACEUTICAL CO., LTD. (JP) 2010-11-11 US claimed
US-7560459-B2 Substituted sulfamate anticonvulsant derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 2009-07-14 US claimed
WO-2008060998-A1 INDOLE SULFONAMIDES AS SFRP-1 MODULATORS WYETH (US) 2008-05-22 WO claimed
EP-1852433-A1 CARBAZOLE DERIVATIVE, SOLVATE THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Zeria Pharmaceutical Co., Ltd. (JP) 2007-11-07 EP claimed
US-7060725-B2 Substituted sulfamate anticonvulsant derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-13 US claimed
US-20060058373-A1 Novel substituted sulfamate anticonvulsant derivatives ABDEL-MAGID AHMED 2006-03-16 US claimed
EP-1506212-A2 NOVEL SUBSTITUTED SULFAMATE ANTICONVULSANT DERIVATIVES Ortho-McNeil Pharmaceutical, Inc. (US) 2005-02-16 EP claimed
US-20040038911-A1 Novel substituted sulfamate anticonvulsant derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 2004-02-26 US claimed
EP-0394829-A1 Renin-inhibiting dipeptides, process to synthetize them, compositions containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1990-10-31 EP claimed
US-4855286-A HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-08 US claimed
US-4754034-A RECORDING MATERIALS, PRESSURE SENSITIVE, THERMOREACTIVE, ELECTROCHROMIC BAYER AKTIENGESELLSCHAFT (DE) 1988-06-28 US claimed
EP-0180813-B1 CHROMOGENIC 4,4-DIARYLDIHYDROCHINAZOLONES, THEIR PREPARATION AND USE BAYER AG (DE) 1988-06-01 EP claimed
EP-0255082-A2 Renin-inhibiting di- and tripeptides, methods for their production, drugs containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1988-02-03 EP claimed
EP-0239874-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application HOECHST AKTIENGESELLSCHAFT (DE) 1987-10-07 EP claimed
EP-0230242-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-07-29 EP claimed
EP-0180813-A1 Chromogenic 4,4-diaryldihydrochinazolones, their preparation and use BAYER AG (DE) 1986-05-14 EP claimed
US-4548926-A RENIN INHIBITOR SANKYO COMPANY LIMITED (JP) 1985-10-22 US claimed
EP-0128762-A2 New hypotensive peptides, their preparation and their use SANKYO COMPANY LIMITED (JP) 1984-12-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038911-A1 Novel substituted sulfamate anticonvulsant derivatives SULT1E1, SULT2A1, GRIK5 TSHR 2222/4885LMNA 4640/4885ALDH1A1 511/4885
US-20100286210-A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof CEL, LIPC, CES1 TSHR 2848/4885LMNA 1355/4885ALDH1A1 551/4885
US-20060058373-A1 Novel substituted sulfamate anticonvulsant derivatives SULT1E1, CACNA1A, SULT2A1 TSHR 1085/4885LMNA 4383/4885ALDH1A1 1011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.